AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (May 19, 2006). doi:10.1152/ajplung.00353.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/L496    most recent
00353.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogel, S.
Right arrow Articles by Malik, A. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, S.
Right arrow Articles by Malik, A. B
Submitted on August 13, 2005
Accepted on February 27, 2006

De novo ICAM-1 Synthesis in the Mouse Lung: Model of Assessment of Protein Expression in Lungs

Stephen Vogel1*, Janie Orrington-Myers1, Michael Broman1, and Asrar B Malik1

1 Pharmacology, University of Illinois College of Medicine, Chicago, Illinois, United States

* To whom correspondence should be addressed. E-mail: vogel{at}uic.edu.

Since most studies addressing the regulatory mechanisms of ICAM-1 expression have used cultured endothelial cells, we set out to develop an isolated mouse lung preparation to study gene and protein expression in its proper cellular context in the organ. Lungs from CD1 mice were isolated and perfused (2 ml/min, 37°C) with a re-circulating volume of RPMI 1640 solution supplemented with 3 g/100 ml albumin. Lungs maintained their isogravimetric state for 4 hr. TNF-{alpha}(2,000 U/ml) was added to the perfusate for 0.5, 1, 2, or 3.5 hr to induce ICAM-1 expression or lungs received no treatment (control). After quick-freezing the lungs using liquid nitrogen at different time points, the prepared tissue homogenates were analyzed for ICAM-1 protein expression by Western blotting and NF-{kappa}B activation by electrophoretic mobility shift assay (EMSA). TNF-{alpha}caused a progressive increase in NF-{kappa}B activity after 0.5 hr and ICAM-1 protein expression 2- to 3-fold of basal after 2 hr. Untreated lungs expressed a low and constant level of ICAM-1 between 0 and 3.5 hr. TNF-{alpha}failed to induce NF-{kappa}B activation and ICAM-1 expression in lungs of NADPH oxidase-deficient mice lacking p47phox (p47phox-/-). We disaggregated mouse lungs using collagenase, and stained the cells for ICAM-1 and VE-cadherin (used as an endothelial marker) to assess the in situ endothelial-specific expression of ICAM-1. We observed that TNF{alpha} challenge resulted in increased ICAM-1 expression in endothelial cells freshly isolated from lungs. These data show the role of NADPH oxidase-derived oxidant signaling in the mechanism of NF-{kappa}B activation and ICAM-1 expression in mouse lung endothelial cells. Moreover, the general method presented herein has potential value in assessing mechanisms of gene and protein expression in the isolated-perfused mouse lung model.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.